LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 243

Search options

  1. Book: The dimishing role of Aspirin in managing cardiovascular disease

    Pollack, Charles V.

    (The American journal of cardiology ; vol. 144, S1 = supplement (April 1, 2021))

    2021  

    Author's details activity chair: Charles V. Pollack, Jr. MD
    Series title The American journal of cardiology ; vol. 144, S1 = supplement (April 1, 2021)
    Collection
    Language English
    Size vi, S47 Seiten, Diagramme
    Publisher Elsevier
    Publishing place Philadelphia, PA
    Publishing country United States
    Document type Book
    HBZ-ID HT020928713
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Reversal of oral anticoagulants

    Pollack, Charles V.

    (The American journal of medicine ; volume 129, number 11A, supplement (November 2016))

    2016  

    Author's details guest editor Charles V. Pollack, Jr., MA, MD
    Series title The American journal of medicine ; volume 129, number 11A, supplement (November 2016)
    Collection
    Language English
    Size Seite S32-S96, Diagramme
    Publisher Elsevier
    Publishing place Maryland Heights, MO
    Publishing country United States
    Document type Book
    HBZ-ID HT019210944
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Book: Reversal of oral anticoagulants

    Pollack, Charles V.

    (The American journal of emergency medicine ; vol 34, no 11S (November 2016))

    2016  

    Author's details guest editor Charles V. Pollack Jr, MA, MD
    Series title The American journal of emergency medicine ; vol 34, no 11S (November 2016)
    Collection
    Language English
    Size 51 Seiten, Illustrationen
    Publisher W.B. Saunders
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT019252233
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Book: Current practice and future considerations for the management of NSTE ACS

    Pollack, Charles V.

    update on the use of antiplatelet agents

    ([The Journal of emergency medicine ; 38,1 Beil.])

    2010  

    Author's details author Charles V. Pollack
    Series title [The Journal of emergency medicine ; 38,1 Beil.]
    The journal of emergency medicine
    Collection The journal of emergency medicine
    Language English
    Size S50 S. : Ill.
    Publisher Elsevier
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT016256524
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article ; Online: ISSUE INTRODUCTION: The Diminishing Role of Aspirin in Cardiovascular Medicine: A Special Supplement to The American Journal of Cardiology.

    Pollack, Charles V

    The American journal of cardiology

    2021  Volume 144 Suppl 1, Page(s) S1

    MeSH term(s) Aspirin/therapeutic use ; Cardiovascular Diseases/drug therapy ; Fibrinolytic Agents/therapeutic use ; Humans
    Chemical Substances Fibrinolytic Agents ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2021-03-12
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.12.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A practice-based approach to emergency department evaluation and management of patients with postacute sequelae after COVID-19 infection: long COVID.

    Chen, Zijian / Pollack, Charles V / Rodriguez, Robert

    Emergency medicine practice

    2024  Volume 26, Issue 1, Page(s) 1–28

    Abstract: Afflicting millions of people across the world, "long COVID" is a new disease entity that can present with a diverse array of symptoms of variable severity, affecting nearly every organ system. The presumptive diagnosis of long COVID is largely clinical, ...

    Abstract Afflicting millions of people across the world, "long COVID" is a new disease entity that can present with a diverse array of symptoms of variable severity, affecting nearly every organ system. The presumptive diagnosis of long COVID is largely clinical, and should be made only after other serious etiologies have been excluded. Workup is driven by the patient's presenting acute symptoms, comorbidities, and physical examination findings. This issue reviews the research and current evidence on the etiology of COVID-19 infection and long COVID and presents a practice-based approach to the management of patients presenting with its postacute sequelae.
    MeSH term(s) Humans ; Post-Acute COVID-19 Syndrome ; COVID-19/therapy ; Patients ; Disease Progression ; Emergency Service, Hospital
    Language English
    Publishing date 2024-01-01
    Publishing country United States
    Document type Journal Article
    ISSN 1559-3908
    ISSN (online) 1559-3908
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Pharmacologic advances in emergency medicine

    Pollack, Charles V.

    (Emergency medicine clinics of North America ; 18,4)

    2000  

    Author's details Charles V. Pollack, guest ed
    Series title Emergency medicine clinics of North America ; 18,4
    Collection
    Language English
    Size VIII S., S. 625 - 857
    Publisher Saunders
    Publishing place Philadelphia u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT012888108
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  8. Article ; Online: The Future of Aspirin Therapy in Cardiovascular Disease.

    Bhatt, Deepak L / Pollack, Charles V

    The American journal of cardiology

    2021  Volume 144 Suppl 1, Page(s) S40–S47

    Abstract: Much has been written about the demise of aspirin (ASA) but reports of its death are premature. The drug remains one of the most widely prescribed by physicians worldwide. It is cheap, familiar, and effective for a variety of uses, including in patients ... ...

    Abstract Much has been written about the demise of aspirin (ASA) but reports of its death are premature. The drug remains one of the most widely prescribed by physicians worldwide. It is cheap, familiar, and effective for a variety of uses, including in patients with acute or prior myocardial infarction, ischemic stroke, peripheral artery disease, and percutaneous or surgical revascularization procedures, as well as for use for pain and fever relief. Beyond physician prescription or recommendation, over the counter use of ASA is common, including for primary cardiovascular prevention, though this decision really should involve a discussion of risks and benefits with a physician. ASA is an essential member of the duo that makes up dual antiplatelet therapy (a P2Y
    MeSH term(s) Aspirin/therapeutic use ; Cardiovascular Diseases/drug therapy ; Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Risk Assessment
    Chemical Substances Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2021-03-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.12.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Evolution of Clinical Thinking and Practice Regarding Aspirin: What Has Changed and Why?

    Pollack, Charles V / Wang, Tracy Y

    The American journal of cardiology

    2021  Volume 144 Suppl 1, Page(s) S10–S14

    Abstract: Aspirin (ASA) is the original antiplatelet agent. Its routine use, long unquestioned for both primary and secondary prevention in cardiovascular disease, is under increasing scrutiny as the risk:benefit balance for ASA becomes less clear and other ... ...

    Abstract Aspirin (ASA) is the original antiplatelet agent. Its routine use, long unquestioned for both primary and secondary prevention in cardiovascular disease, is under increasing scrutiny as the risk:benefit balance for ASA becomes less clear and other disease- and risk-modifying approaches are validated. It can be viewed as a significant advance in evidence-based medicine that the use of an inexpensive, readily available, long-validated therapy is being questioned in large, rigorous trials. In this overview we present the important questions surrounding a more informed approach to ASA therapy: duration of therapy, assessment of net clinical benefit, and timing of start and stop strategies. We also consider potential explanations for "breakthrough" thrombosis when patients are on ASA therapy. Other manuscripts in this Supplement address the specifics of primary prevention, secondary prevention, triple oral antithrombotic therapy, and the future of ASA in cardiovascular medicine.
    MeSH term(s) Aspirin/therapeutic use ; Cardiovascular Diseases/drug therapy ; Drug Administration Schedule ; Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Risk Assessment
    Chemical Substances Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2021-03-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.12.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus?

    Milling, Truman J / Pollack, Charles V

    The American journal of emergency medicine

    2020  Volume 38, Issue 9, Page(s) 1890–1903

    Abstract: Anticoagulation is key to the treatment/prevention of thromboembolic events. The primary complication of anticoagulation is serious or life-threatening hemorrhage, which may necessitate prompt anticoagulation reversal; this could also be required for ... ...

    Abstract Anticoagulation is key to the treatment/prevention of thromboembolic events. The primary complication of anticoagulation is serious or life-threatening hemorrhage, which may necessitate prompt anticoagulation reversal; this could also be required for nonbleeding patients requiring urgent/emergent invasive procedures. The decision to reverse anticoagulation should weigh the benefit-risk ratio of supporting hemostasis versus post-reversal thrombosis. We appraise the available guidelines/recommendations for vitamin K antagonist (VKA) and direct oral anticoagulant (DOAC) reversal in the management of major bleeding, and also assess recent clinical data that may not yet be reflected in official guidance. In general, available guidelines are consistent in their recommendations, advocating administration of vitamin K and 4-factor prothrombin complex concentrates (4F-PCCs) rather than fresh frozen plasma to patients with VKA-associated intracranial hemorrhage and life-threatening bleeding, and specific reversal agents as essential therapy for DOAC reversal in those same severe conditions. However, guidelines also recommend off-label use of PCCs for DOAC reversal when specific reversal agents are unavailable. Limited recent evidence generally support the latter recommendation, but guidelines are likely to evolve as more data become available.
    MeSH term(s) Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Consensus ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy ; Humans ; Practice Guidelines as Topic ; Vitamin K/antagonists & inhibitors
    Chemical Substances Anticoagulants ; Vitamin K (12001-79-5)
    Language English
    Publishing date 2020-05-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 605890-5
    ISSN 1532-8171 ; 0735-6757
    ISSN (online) 1532-8171
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2020.05.086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top